| Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease |
| CAD/CAM versus traditional indirect methods in the fabrication of inlays, onlays, and crowns |
| Caesarean delivery for the second twin |
| Caesarean section for non-medical reasons at term |
| Caesarean section versus vaginal delivery for preterm birth for women with a single baby (not multiple birth) |
| Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission |
| Caffeine as an analgesic adjuvant for acute pain in adults |
| Caffeine for cognition |
| Caffeine for preventing injuries and errors in shift workers |
| Caffeine versus theophylline for apnea in preterm infants |
| Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients |
| Calcineurin inhibitor minimisation, ie, reduction or withdrawal, versus continuation of calcineurin inhibitor treatment for liver transplant patients |
| Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients |
| Calcitonin for preventing and treating corticosteroid-induced osteoporosis |
| Calcitonin testing for detection of medullary thyroid cancer in patients with thyroid nodules |
| Calcitonin used to treat metastatic bone pain |
| Calcium and vitamin D for improving bone health in healthy premenopausal women |
| Calcium and vitamin D for treating osteoporosis caused by the use of steroids |
| Calcium antagonists as an add-on therapy for drug-resistant epilepsy |
| Calcium antagonists for acute ischemic stroke |
| Calcium antagonists for aneurysmal subarachnoid haemorrhage |
| Calcium antagonists for unstable angina |
| Calcium channel blockers as medical expulsive therapy for ureteric stones |
| Calcium channel blockers can reduce the death of tubular cells in the kidney after a transplant operation |
| Calcium channel blockers for antipsychotic-induced tardive dyskinesia |
| Calcium channel blockers for inhibiting preterm labour and birth |
| Calcium channel blockers for people with chronic kidney disease requiring dialysis |
| Calcium channel blockers for potential impaired fetal growth |
| Calcium channel blockers for preventing heart dysfunction related to iron overload in transfusion-dependent beta thalassaemia |
| Calcium channel blockers for primary Raynaud's phenomenon |
| Calcium channel blockers for pulmonary arterial hypertension |
| Calcium channel blockers for treatment of patients with Raynaud’s phenomenon |
| Calcium channel blockers versus other classes of drugs for hypertension |
| Calcium channel blocking drugs for Duchenne muscular dystrophy |
| Calcium for improving bone mineral density in children |
| Calcium supplementation during pregnancy for preventing blood pressure disorders and related problems |
| Calcium supplementation for the management of primary hypertension in adults |
| Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism |
| Call for #CochraneLondon Social Media Ambassadors - Let's get social |
| Call for 'Expressions of Interest' to Join the Cochrane US Network now open |
| Call for abstracts: Shape the future of evidence at the 2024 Global Evidence Summit |
| Call for nominations: Cochrane seeks two external members to join Board |
| Calling all Citizen Scientists! Join the CitSciMed Blitz! |
| Calorie labelling leads to modest reductions in selection and consumption |
| Calorie-controlled diets for chronic asthma |
| Campaigning for Evidence: Sara Yaron - a patient's story |
| Campaigns to encourage children to wear cycle helmets |
| Can 'perfusion' machines improve the quality of livers donated for transplantation? |
| Can a class of antidiabetic medicine help protect the brain after a severe ischemic (caused by a blocked blood vessel) stroke? |
| Can a dementia medicine (memantine) help people with autism spectrum disorder? |
| Can a first dose of whole-cell whooping cough vaccine given before six months old prevent allergic diseases in childhood? |
| Can additional chemotherapy after initial treatment for locally advanced stage cervical cancer reduce recurrence and extend life? |
| Can antibody induction therapy help to reduce organ rejection for lung transplant recipients? |
| Can apps be used for the delivery of survey questionnaires in public health and clinical research? |
| Can assistive technology help improve stiff joints caused by shortened muscles and tendons in adults after a stroke? |
| Can biomarkers improve predictions of the RCRI tool to predict heart-related complications in patients undergoing surgery other than heart surgery? |
| Can breastfeeding support interventions that target depression prevent the development of depression after childbirth? |
| Can breathing support using continuous positive airway pressure (CPAP), given within the first hour of life, prevent death and illness in premature babies? |
| Can brief interventions delivered in schools reduce substance use among adolescents? |
| Can calorie (energy) labelling change people's selection and consumption of food or alcohol? |
| Can cannabinoid type 1 receptor antagonists help smokers to quit, and could they also reduce the amount of weight gained during the quitting process? |
| Can changing antipsychotic medication improve side effects like increases in weight, blood sugar and cholesterol? |
| Can cognitive behavioural therapy reduce harmful sexual behaviour in adolescents? |
| Can cognitive stimulation benefit people with dementia? |
| Can cognitive stimulation benefit people with dementia? |
| Can cognitive stimulation benefit people with dementia? |
| Can collecting blood that is lost during surgery, and returning it to the patient, reduce the need to use donated blood for that patient? |
| Can collecting blood that is lost during surgery, and returning it to the patient, reduce the need to use donated blood for that patient? |
| Can combined mechanical and oral antibiotic bowel preparation reduce the risk of complications after scheduled colon or rectal resections compared with purely mechanical, purely oral antibiotic or no bowel preparation? |
| Can community interventions deter young people from starting to smoke? |
| Can community interventions reduce smoking among adults |
| Can community pharmacy interventions help improve pharmacy workers' skills and pharmacy users' health outcomes through health promotion? |
| Can cytokines and growth factors help prevent mouth soreness and ulcers (oral mucositis) in patients being treated for cancer? |
| Can day care programs for children under 6 years of age in low- to middle-income countries reduce their risk of drowning? |
| Can dental professionals help people to stop smoking or using tobacco products? |
| Can dihydrocodeine reduce illegal opiate use in adolescents and adults? |
| Can dopamine agonists prevent ovarian hyperstimulation syndrome in women undergoing fertility treatment with IVF or ICSI? |
| Can dressings, creams, or oils help prevent pressure ulcers (bed sores)? |
| Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose? |
| Can electronic cigarettes help people stop smoking, and do they have any unwanted effects when used for this purpose? |
| Can endoscopic sinus surgery (i.e. surgery using a long thin tube inserted into the sinuses) help to treat nasal polyposis (soft growths in the nasal passages called polyps) in people with cystic fibrosis (CF)? |
| Can ethical case interventions improve healthcare? |
| Can exenatide, a diabetes drug, be used to treat Parkinson's disease? |
| Can exercise give better results after spinal surgery for spinal stenosis? |
| Can exercise help people quit smoking? |
| Can exercise interventions enhance health-related quality of life among cancer survivors? |
| Can exercise interventions enhance health-related quality of life among people with cancer undergoing active treatment? |
| Can exercise, for women with gestational diabetes, improve outcomes for mother and her baby? |
| Can exercising before vaccination reduce numbers of adults who get flu or develop complications? |
| Can exhaled nitric oxide be used to adjust asthma medications in children with asthma? |
| Can hand hygiene prevent infection in newborn babies? |
| Can health care providers who are not doctors perform abortions as well as doctors? |
| Can illegal cigarette sales to underage youth be prevented, and does it change their smoking behaviour |
| Can individual caseworker-assigned discharge plans reduce readmissions for acute exacerbations in children with chronic respiratory disease? |
| Can injection of platelet-rich plasma in the womb or ovaries of infertile women undergoing assisted reproduction help them to become pregnant? |
| Can inserting a cervical stitch prevent early births of single babies? |
| Can international travel-related control measures contain the spread of the COVID-19 pandemic? |
| Can Internet-based interventions help people to stop smoking? |
| Can interventions for parents and people caring for children reduce children's exposure to tobacco smoke? |
| Can interventions to improve professional adherence to guidelines prevent device-related infections? |
| Can keeping the mouth cold during cancer treatment help to prevent mouth soreness and ulcers in children and adults? |
| Can lay health workers effectively identify and treat wasting in children? |
| Can lobeline help people to quit smoking |
| Can mass media campaigns (television, radio, newspapers, billboards and booklets) deter young people from starting to smoke? |
| Can medications like varenicline and cytisine (nicotine receptor partial agonists) help people to stop smoking and do they cause unwanted effects? |
| Can medications like varenicline and cytisine (nicotine receptor partial agonists) help people to stop smoking and do they cause unwanted effects? |
| Can medicines prevent venous thromboembolism after weight-loss surgery? |
| Can medicines that block interleukin-6 (a protein involved in immune responses) treat COVID-19? |
| Can mefloquine prevent malaria during travel to areas where the disease is widespread? |
| Can mindfulness help people to stop smoking? |
| Can mouthwashes or nasal sprays protect healthcare workers and patients from COVID-19 infection? |
| Can music and vocal interventions benefit preterm infants and their parents? |
| Can music and vocal interventions benefit preterm infants and their parents? |
| Can music and vocal interventions benefit preterm infants and their parents? |
| Can music interventions benefit people with cancer? |
| Can music interventions replace sedatives for reduction of preoperative anxiety? |
| Can nicotine replacement therapy (NRT) help people quit smoking? |
| Can nicotine vaccines help people stop smoking or help stop recent quitters from relapsing? |
| Can non-medicinal measures prevent or reduce SARS-CoV-2 infections in long term care facilities? |
| Can non-pharmacological measures prevent or reduce Covid-19 (SARS-CoV-2) infections in long term care facilities? |
| Can ocular antibiotics treatment prevent eye infection following a corneal abrasion? |
| Can oral Astragalus (Huang qi) prevent frequent acute respiratory tract infections in children? |
| Can organisational infrastructures be effective in promoting evidence-based nursing practice? |
| Can people be helped to stop smoking before they have surgery? |
| Can people stop smoking by cutting down the amount they smoke first? |
| Can percussion, diuresis, and inversion therapy improve outcomes for people with lower pole kidney stones following shock wave lithotripsy? |
| Can physical exercise improve blood flow in people with chronic venous insufficiency? |
| Can pressure ulcers be prevented by using different support surfaces? |
| Can probiotics (live micro-organisms) prevent upper respiratory tract infections such as the common cold? |
| Can programmes delivered by mobile phones help people to stop smoking? |
| Can programmes delivered in school prevent young people from starting to smoke? |
| Can programmes on social media help people to improve their health? |
| Can psychological or educational interventions (or combinations of both) reduce falls in older adults who live at home? |
| Can psychological or educational interventions (or combinations of both) reduce falls in older adults who live at home? |
| Can psychological therapies help people who self-harm? |
| Can psychosocial interventions reduce antipsychotic medication in care home residents? |
| Can psychosocial interventions reduce antipsychotic medication in care home residents? |
| Can recruitment strategies make smokers more likely to enter programmes to help them quit smoking? |
| Can reducing prescriptions of anticholinergic medicines improve cognitive outcomes in older adults? |
| Can rewards help people quit smoking, and do they work in the long term? |
| Can self-management programs improve the quality of life in adults with low vision? |
| Can services delivered by pharmacists improve patient health? |
| Can shared decision-making between the patient and the healthcare professional help people with asthma? |
| Can smartphone apps improve access to asthma self management? |
| Can smokers be helped to reduce the harm caused by cigarette smoking by smoking fewer cigarettes or using different tobacco products? |
| Can smoking cessation interventions among adults with pulmonary tuberculosis improve their tuberculosis treatment outcomes? |
| Can strategies intended to improve how care is organised or delivered to people with overweight or obesity lead to greater weight reduction? |
| Can taking inhaled corticosteroids when needed for symptoms help people with mild asthma from becoming more unwell? |
| Can tests for inflammation help doctors decide whether to use antibiotics for airway infections? |
| Can tests for inflammation help doctors decide whether to use antibiotics for airway infections? |
| Can tests to identify the main draining lymph nodes in women with endometrial cancer accurately diagnose if the cancer has spread to the lymph nodes? |
| Can tests used to identify the main groin lymph node/s in women with vulval cancer accurately predict whether the cancer has spread to the groin/s? |
| Can text message reminders help people with heart disease take their medications regularly? |
| Can the glucose-lowering drugs insulin secretagogues prevent or delay type 2 diabetes mellitus and its associated complications in persons at increased risk of this disease? |
| Can the medicine dexrazoxane prevent or reduce heart damage in adults and children with cancer receiving anthracyclines? |
| Can the public release of performance data in health care influence the behaviour of consumers, healthcare providers, and organisations? |
| Can the use of antibiotics prevent an infection when a retained placenta is removed by hand after vaginal birth? |
| Can the use of standardised packaging for tobacco products reduce the use of tobacco? |
| Can third-party inspections of whether healthcare organisations are fulfilling mandatory standards improve healthcare outcomes? |
| Can tobacco control programmes that include a mass media campaign help to reduce levels of smoking among adults? |
| Can training health professionals to ask people if they smoke increase offers of advice and help patients quit? |
| Can ultrasound therapy help to heal venous (varicose) leg ulcers and/or improve symptoms? |
| Can users of waterpipes be helped to quit through smoking cessation interventions? |
| Can vasodilators (medicines that widen blood vessels) help women with infertility have children? |
| Can virtual reality training for cataract surgery supplement or replace other training methods for ophthalmology trainees? |
| Can we help smokers to increase their use of stop-smoking medicines? |
| Can xylitol used in products like sweets, candy, chewing gum and toothpaste help prevent tooth decay in children and adults? |
| Canadian C-spine rule and the National Emergency X-Radiography Utilization Study (NEXUS) for detecting clinically important cervical spine injury following blunt trauma |
| Cancer genetic risk assessment for individuals at risk of familial breast cancer |
| Cancer patients with fever and suspected infection can be treated with a single 'new-generation' beta-lactam antibiotic |
| Cannabidiol for people with schizophrenia |
| Cannabinoids for epilepsy |
| Cannabinoids for the treatment of dementia |
| Cannabinoids for Tourette syndrome |
| Cannabis and cannabinoids for people with multiple sclerosis |
| Cannabis and cannabinoids for people with multiple sclerosis |
| Cannabis and cannabis oil for the treatment of Crohn's disease |
| Cannabis and cannabis oil for the treatment of ulcerative colitis |
| Cannabis for schizophrenia |
| Cannabis products for adults with chronic neuropathic pain |
| Cannabis products for people with fibromyalgia |
| Cannabis-based medicine for nausea and vomiting in people treated with chemotherapy for cancer |
| Cannabis-based medicines for cancer pain |
| Cannabis-based medicines for cancer pain |
| Cannabis-based medicines for prevention of postoperative nausea and vomiting in adults |
| Capsaicin applied to the skin for chronic neuropathic pain in adults |
| Capsaicin for allergic rhinitis |
| Capsaicin for non-allergic rhinitis |
| Capsule endoscopy for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis |
| CAR T-cell therapy for people with diffuse large B-cell lymphoma which returns after treatment or no longer responds to treatment |
| Carbamazepine and oxcarbazepine for the treatment of behavioural and psychological symptoms of dementia (BPSD) |
| Carbamazepine does not appear to be effective in reducing cocaine dependence, with high dropout rates and adverse effects |
| Carbamazepine for chronic neuropathic pain and fibromyalgia in adults |
| Carbamazepine for schizophrenia |
| Carbamazepine versus phenobarbitone monotherapy (single drug treatment) for epilepsy |
| Carbamazepine versus phenytoin (given as a single drug treatment) for epilepsy |
| Carbamazepine versus valproate monotherapy for epilepsy |
| Carbetocin for preventing postpartum haemorrhage |
| Carbohydrate or fat-restricted diets for obesity |
| Carbohydrate supplementation of human milk to promote growth in preterm infants |
| Carbon dioxide detection for testing nasogastric tube placement in adults |
| Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease |
| Cardiac resynchronization therapy for dilated cardiomyopathy |
| Cardiac testing for coronary artery disease in potential kidney transplant recipients |
| Cardioselective beta-blockers for reversible airway disease |
| Cardiotocography (a form of electronic fetal monitoring) for assessing a baby's well-being in the womb during pregnancy |
| Cardiotocography for antepartum fetal assessment |
| Cardiovascular safety of phosphodiesterase inhibitors for treating erectile dysfunction in elderly men |
| Care co-ordination interventions to improve outcomes during pregnancy and early childhood (up to 5 years) |
| Care delivery and self management strategies for adults with epilepsy |
| Care delivery and self-management strategies for children with epilepsy |
| Care for pregnant women who have experienced genital cutting |
| Care involving families for Indigenous early childhood well-being |
| Care involving families for Indigenous early childhood well-being |
| Care pathways versus usual care for chronic obstructive pulmonary disease (COPD) |
| Care planning or case management for frequent emergency department attendance in adults |
| Care prior to the next pregnancy for women diagnosed with gestational diabetes |
| Caregiver-mediated exercises for improving outcomes after stroke |
| Cariprazine versus placebo for schizophrenia |
| Carisbamate add-on therapy for drug-resistant focal epilepsy |
| Carnitine for fatigue in patients with multiple sclerosis (MS) |
| Carnitine supplementation for preterm infants with recurrent apnoea |
| Carnitine supplementation of parenterally fed neonates |
| Carnitine supplements for people with chronic kidney disease requiring dialysis |
| Carnitine supplements for treating people with inborn errors of metabolism |
| Carotid endarterectomy for asymptomatic carotid stenosis |
| Carotid endarterectomy for carotid stenosis in patients selected for coronary artery bypass graft surgery |
| Carotid revascularisation versus medical treatment for asymptomatic carotid artery stenosis |
| Carotid surgery in people who have symptoms with narrowing of the carotid artery |
| Case management approaches to home support for people with dementia |
| Case management for people with severe mental disorders |
| Case management programmes for older people living with frailty in the community |
| Case management programmes for older people living with frailty in the community |
| Case management: effects on professional practice and health care outcomes |
| Case mangement for persons with substance use disorders. |
| Castor oil, bath and/or enema for cervical priming and induction of labour |
| Cataract surgery in people with age-related macular degeneration |
| Catherine Marshall appointed Co-Chair of the Governing Board |
| Catherine Marshall re-appointed Co-Chair of the Governing Board |
| Catherine Spencer steps down as CEO of Cochrane |
| Catherine Spencer to join Cochrane as new Chief Executive Officer |
| Catheter ablation for atrial fibrillation |
| Catheter ablation versus escalation of antiarrhythmic medications for management of ventricular tachycardia in patients with ischaemic heart disease |
| Catheter ablation versus pharmacological treatment for patients with Wolff-Parkinson-White syndrome |
| Catheter ablation would be an alternative to inhibit recurrence of paroxysmal or persistent atrial fibrillation |
| Catheter insertion techniques for improving catheter function and clinical outcomes in peritoneal dialysis patients |
| Catheter lock treatments for catheter-related infections in children with cancer |
| Catheter policies for management of long-term voiding problems in adults with nerve damage affecting the bladder |
| Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients |
| Cefepime versus other beta-lactam antibiotics for the treatment of infections in non-neutropenic patients |